Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.29 USD | -0.29% |
|
+4.20% | -35.22% |
06-03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
05-30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.22% | 3.99B | |
+38.36% | 52.73B | |
+38.37% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Immunovant Insider Sold Shares Worth $504,567, According to a Recent SEC Filing